| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Multiple Scleiosis Center, Marshfield Clinic (Dr. Rolak), Marshfield, WI; Jaeb Center for Health Research, Inc. (Dr. Beck), Tampa, FL; University of British Columbia (Dr. Paty), Vancouver, BC. Canada; Wadsworth Veterans Administration Medical Center (Dr. Tourtellotte), Los Angeles, CA; University of Alabama at Birmingham (Dr. Whitaker), Birmingham, AL; and The Mellen Center, Cleveland Clinic (Dr. Rudick), Cleveland, OH.
Received March 7, 1995. Accepted in final form June 16, 1995.
Address correspondence and reprint requests to Dr. Loren A. Rolak, Multiple Sclerosis Center, The Marshfield Clinic, 1000 N. Oak Avenue, Marshfield, WI 54449.
The Optic Neuritis Treatment Trial (ONTT) is a prospective study of corticosteroid treatment of acute optic neuritis (ON), with subsequent longitudinal follow-up to determine development of clinically definite multiple sclerosis (CDMS). We analyzed the CSF of 83 patients with clinically isolated ON who underwent lumbar puncture within 24 hours of enrollment into the ONTT to determine the value of CSF changes in ON, especially regarding diagnostic utility, immunologic changes, MRI correlations, and progression to CDMS All patients had baseline MRI scans graded for changes typical of MS CSF measurements included immunoglobulin G (IgG) synthesis, IgG ratio, myelin basic protein, IgG kappa light chains, and oligoclonal banding. No patients had their diagnosis or management altered as a result of CSF findings. Except for oligoclonal bands, few patients showed any abnormalities on CSF tests, and no tests correlated with the 2-year development of CDMS. Oligoclonal banding, present at baseline in 11 of 13 patients who developed CDMS, did predict progression to CDMS, but this was not independent of MRI abnormalities. Two patients with oligoclonal bands and a normal MRI did progress to CDMS. We conclude that CSF analysis may not be necessary in the routine evaluation of patients presenting with a typical clinical profile of acute ON, and that most CSF tests add little additional information to MRI results for predicting the 2-year development of CDMS. However, the precise role of oligoclonal banding in the analysis of such patients awaits longer follow-up of this cohort.
NEUROLOGY 1996,46 368-372
This article has been cited by other articles:
|
|
 |
|
  M Tintore and J Sastre-Garriga Role of MRI criteria and OB for diagnosing multiple sclerosis in patients presenting with clinically isolated syndromes Multiple Sclerosis, April 1, 2009; 15(4): 407 - 408. [PDF]
|
|
|
|
 |
|
 C. F. Lucchinetti, R. H. Gavrilova, I. Metz, J. E. Parisi, B. W. Scheithauer, S. Weigand, K. Thomsen, J. Mandrekar, A. Altintas, B. J. Erickson, et al. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis Brain, July 1, 2008; 131(7): 1759 - 1775. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tintore, A. Rovira, J. Rio, C. Tur, R. Pelayo, C. Nos, N. Tellez, H. Perkal, M. Comabella, J. Sastre-Garriga, et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology, March 25, 2008; 70(13_Part_2): 1079 - 1083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Balcer Clinical practice. Optic neuritis. N. Engl. J. Med., March 23, 2006; 354(12): 1273 - 1280. [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Freedman, E. J. Thompson, F. Deisenhammer, G. Giovannoni, G. Grimsley, G. Keir, S. Ohman, M. K. Racke, M. Sharief, C. J. M. Sindic, et al. Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple Sclerosis: A Consensus Statement Arch Neurol, June 1, 2005; 62(6): 865 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Tintore, A Rovira, L Brieva, E Grive, R Jardi, C Borras, and X Montalban Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS Multiple Sclerosis, December 1, 2001; 7(6): 359 - 363. [Abstract] [PDF]
|
|
|
|
|
|
D. I. Kaufman, J. D. Trobe, E. R. Eggenberger, and J. N. Whitaker Practice parameter: The role of corticosteroids in the management of acute monosymptomatic optic neuritis: Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology, June 13, 2000; 54(11): 2039 - 2044. [Full Text] [PDF]
|
|
|
|
|
|
F. Sellebjerg, M. Christiansen, P. M. Nielsen, and J. L Frederiksen Cerebrospinal fluid measures of disease activity in patients with multiple sclerosis Multiple Sclerosis, December 1, 1998; 4(6): 475 - 479. [Abstract] [PDF]
|
|
|
|
|
|
J L Frederiksen Can CSF predict the course of optic neuritis? Multiple Sclerosis, June 1, 1998; 4(3): 132 - 135. [Abstract] [PDF]
|
|
|
|
|
|
J. N Whitaker Myelin basic protein in cerebrospinal fluid and other body fluids Multiple Sclerosis, February 1, 1998; 4(1): 16 - 21. [Abstract] [PDF]
|
|
|
|
|
|
J. L Frederiksen and C. J. Sindic Intrathecal synthesis of virus-specific oligoclonal IgG, and of free kappa and free lambda oligoclonal bands in acute monosymptomatic optic neuritis. Comparison with brain MRI Multiple Sclerosis, February 1, 1998; 4(1): 22 - 26. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
